Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Precision Biosciences (DTIL) Interest & Investment Income (2018 - 2025)

Historic Interest & Investment Income for Precision Biosciences (DTIL) over the last 8 years, with Q3 2025 value amounting to $1.0 million.

  • Precision Biosciences' Interest & Investment Income fell 4174.7% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year decrease of 3010.15%. This contributed to the annual value of $6.8 million for FY2024, which is 1200.88% down from last year.
  • As of Q3 2025, Precision Biosciences' Interest & Investment Income stood at $1.0 million, which was down 4174.7% from $1.1 million recorded in Q2 2025.
  • Precision Biosciences' 5-year Interest & Investment Income high stood at $2.0 million for Q1 2023, and its period low was $44000.0 during Q3 2021.
  • Over the past 5 years, Precision Biosciences' median Interest & Investment Income value was $1.3 million (recorded in 2025), while the average stood at $1.1 million.
  • As far as peak fluctuations go, Precision Biosciences' Interest & Investment Income plummeted by 9196.97% in 2021, and later surged by 297460.32% in 2022.
  • Quarter analysis of 5 years shows Precision Biosciences' Interest & Investment Income stood at $63000.0 in 2021, then soared by 2974.6% to $1.9 million in 2022, then fell by 5.68% to $1.8 million in 2023, then decreased by 18.23% to $1.5 million in 2024, then plummeted by 31.26% to $1.0 million in 2025.
  • Its last three reported values are $1.0 million in Q3 2025, $1.1 million for Q2 2025, and $1.3 million during Q1 2025.